Company Profile

Aclara Biosciences Inc (AKA: Soane BioSciences, Inc)
Profile last edited on: 3/8/19      CAGE:       UEI:

Business Identifier: Lab-on-a-chip: protein-based assays for personalized medicine
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1288 Pear Avenue
Mountain View, CA 94043
   (650) 210-1200
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Originally dba Soane BioSciences, Inc, around 1998 the firm was renamed Aclara Biosciences. In December 2004 Virologic (an SBIR company) merged with Aclara Biosciences Inc. creating a company that focused on developing and commercializing targeted therapeutics and molecular diagnostics in the areas of cancer and infectious diseases such as HIV. A spin-off of Sloan Technologies, ACLARA Biosciences, Inc. had been an early establsihed bio-tech/ life sciences company focused on developing and commercializing assay chemistry solutions for drug discovery and development, providing critical high-value information about the expression and interaction of genes and proteins within cells. The Company develops, manufactures and supplies these biology assays as part of its eTag Assay System. The system is comprised of reagent kits, software and services that simplify and automate various aspects of drug development, preclinical testing and clinical assessment. The eTag assays require no sample preparation steps, and provide for simultaneous analysis of tens of hundreds of different biological analyses across tens of thousands of samples. This multiplexing capability is critical to the overall performance of eTag assays. eTag assays represent a universal platform for the analysis of genes, proteins and cellular pathways and can be analyzed using existing capillary electrophoresis instrumentation systems.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $99,007
Project Title: Development of a Novel Temperature Cycling Approach
1997 2 NIH $849,994
Project Title: Replaceable Gels for Microchannel DNA Electrophoresis
1996 1 NIH $100,000
Project Title: Solid Phase Extraction Capillary Electrophoresis
1996 1 NIH $100,000
Project Title: Rapid, Point-Of-Care Test for Myocardial Infarction
1995 1 NIH $100,000
Project Title: Constant Field Electrophoresis of Large DNA

Key People / Management

  Thomas Baruch -- President

  Herbert Hooper

  Randy M McCormick

  Alexander Sassi

  David S Soane

Company News

There are no news available.